报价延迟最少15分钟:2025/08/25 19:11 EDT
盘后时段
|
||||
|
4.65 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.65
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.97/-0.16
|
|
企业价值
176.94M
|
| 资产负债 |
|
每股账面净值
-0.48
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
64.25M
|
|
每股收益
1.51
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/08/25 19:11 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US. |
